Development of aplastic anemia during treatment of anaplastic astrocytoma with temozolomide

Authors

Karam Khaddour, Washington University School of Medicine in St. Louis
Nigel Harrison, Washington University School of Medicine in St. Louis
Ashwin Govindan, Washington University School of Medicine in St. Louis
Jian L. Campian, Washington University School of Medicine in St. Louis

Journal

Case Reports in Oncology

Publication Date

2020

Volume

13

Issue

3

First Page

1244

Last Page

1251

Document Type

Open Access Publication

DOI

10.1159/000509744

Rights and Permissions

Khaddour K, Harrison N, Govindan A, Campian J, L: Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide. Case Rep Oncol 2020;13:1244-1251. doi: 10.1159/000509744 This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC)(http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. The final, published version of this article is available at http://www.karger.com/?doi=10.1159/000509744

Recommended Citation

Khaddour, Karam; Harrison, Nigel; Govindan, Ashwin; and Campian, Jian L., "Development of aplastic anemia during treatment of anaplastic astrocytoma with temozolomide." Case Reports in Oncology. 13, 3. 1244 - 1251. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9816